Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →
Help us improve your experience. Please confirm your investor type:
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
FTXH ETF · First Trust Nasdaq Pharmaceuticals ETF
Performance & flows
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | +2.97%  | +0.94%  | +39.92% | +32.02%  | +39.07% | -1.03% | -1.03% | +3.34% | |
| Flows |
Key fund info
Essentials
Enterprise
Similar ETFs in your region
Advertisement
Risk profile
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | +0.94% | +39.92% | +32.02% | +39.07% |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Exposure
Sustainability
ESG Consensus® by Conser
Our partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about FTXH ETF's sustainability, based on their methodology.
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
FTXH’s has a Final Sustainability Grade of either A+, A, or A-.
Replication
Issuer
| AuM | ||
|---|---|---|
RDVY | First Trust NASDAQ Rising Dividend Achievers ETF | €18.74B |
SDVY | First Trust SMID Cap Rising Dividend Achievers ETF | €9.34B |
CIBR | First Trust NASDAQ Cybersecurity ETF | €8.64B |
AIRR | First Trust RBA American Industrial Renaissance ETF | €8.48B |
GRID | First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund ETF | €8.24B |
Frequently asked questions about FTXH
What does First Trust Nasdaq Pharmaceuticals ETF, FTXH, invest in?
FTXH is a Passive ETF. This ETF provides exposure to Other US Pharmaceuticals Equities.
Which benchmark or index does FTXH replicate?
FTXH tracks the NASDAQ US Smart Pharmaceuticals Total Return Index - USD, through a optimized sampling replication method.
What is the Total Expense ratio (TER) of FTXH?
FTXH carries a total expense ratio (TER) of 0.6%, indicating the annual cost for holding the fund.
When was FTXH launched?
FTXH was introduced to the market on September 20, 2016. It trades on United States
Who is the ETF issuer of FTXH?
First Trust Nasdaq Pharmaceuticals ETF, FTXH, is provided by First Trust. Learn more about First Trust here.
What is the current assets under management (AUM) of FTXH?
FTXH oversees €26M in assets as of April 23, 2026.
How has FTXH performed lately?
Based on data from April 23, 2026, FTXH returned 2.97% over the past month, 0.94% over the last three months and 3.34% year-to-date.
What are the latest inflows or outflows for FTXH?
As of April 23, 2026, FTXH recorded net flows of +€1.5M over the last month and +€7.3M year-to-date.
Does FTXH distribute dividends?
FTXH follows a distributing dividend policy, meaning it pays out income to investors. As of April 23, 2026, its 12-month trailing yield was 1.24%.
What are the main country or region exposures of FTXH?
As of March 31, 2026, FTXH has significant geographic allocations in USA and Ireland.
In which sector or theme does FTXH invest in?
As of March 31, 2026, FTXH focuses largely on Health Care.
How many securities does FTXH hold and how diversified is it?
As of March 31, 2026, FTXH holds 50 positions in its portfolio, with 71.00% of assets concentrated in its top 15 holdings.
What are the main positions in FTXH?
As of March 31, 2026, FTXH top three holdings include BRISTOL-MYERS SQUIBB, JOHNSON&JOHNSON and MERCK & CO INC.
What is the base currency of FTXH?
The base currency of FTXH is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
